Close
CDMO Safety Testing 2026
Novotech

Press Releases

Avance Clinical Invited to Present “Decentralized Trials – No Going Back” for Oracle Health Sciences Connect

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been invited to present on the future of decentralized clinical trials at the Oracle Health Sciences Connect conference. Title: Decentralized Trials...

DFE Pharma Launches Ultimate Excipient Solution for Biopharma

DFE Pharma, a global leader in pharmaceutical excipient solutions is excited to announce the launch of its new product line BioHaleยฎ, to address worldwide supply challenges for biopharmaceutical companies. Recent developments in the field of biologics have provided unique therapy...

Sinocompound expands range with new advanced high-quality Buchwald ligands and precatalysts

Sinocompound Catalysts Co., Ltd has added to its established range of Buchwald ligands and precatalysts providing customers with even greater choice of ligands to meet their cross-coupling needs. Sinocompound is a specialist global provider of advanced homogeneous catalysts and...

Philanthropy Forest Inc.’s Matthew Hall Announces a Call to Action to Fund the Planting of 1 Million Trees in 5 Years in National Forests

St. Charles, IL As part of Philanthropy Forest Inc.โ€™s climate change endeavor, Philanthropy Forest Inc. calls on the Pharmaceutical Industry for funding to plant 1 million trees in 5 years in National Forests. Millions have been spent on the โ€œGo...

TraceLink Introduces Opus, the Digital Supply Network Creation Platform, Enabling Industries to Work Together with Collective Intelligence

TraceLink Inc., the leading digital network platform company, announced the availability of its new Opus platform. Built on top of TraceLink's network of 283,000 members, Opus is a digital supply network creation platform that provides a low-code environment for...

Sanofi to invest in a leading-edge production site in Singapore; continues to strengthen its vaccines manufacturing capacities

Sanofi announced a โ‚ฌ400 million investment over five years to create a unique vaccine production center in Singapore, pushing the boundaries of operations through cutting edge manufacturing and digital technologies. In partnership with the Singapore Economic Development Board (EDB),...

FBL pioneers the development of its patented enzymatic route of synthesis for Molunpiravir an investigational ” orally active” therapeutic alternative for COVID 19

โ€œWith the more we understand of COVID 19 the less we fear it and it is through this understanding that we can potentially create impressive therapeutic developmentsโ€ says Mr. Prashant Nagre, CEO, FBL as he expounds further on the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป